The idea that ART can affect COVID-19 comes from the fact that it can inhibit the production of IL-1B, IL-6 and IL-8 by inhibiting NF-κB translocation in a dose-dependent manner in vitro [126]. This evidence concerns the gene IL6 and COVID-19.